Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team
Regulatory press release

OBSRV: Observe Medical has received first significant UnoMeterT SafetiT Plus order from Italy

Observe Medical
Oslo, 6 March, 2025 -Observe Medical ("the Company" or "Observe Medical") has
received a significant repeat order from the very important Italian market that
in 2021 represented almost 20 mNOK of the total UnoMeterT annual sales.

After testing UnoMeterT SafetiT Plus at key customers in the Italian market and
subsequently received very positive feedback on the performance and quality of
the product, the first significant order has been received from the Italian
distributor.

In parallel with the new UnoMeterT SafetiT Plus sales there are already
significant sales of UnoMeterT 500 in the Italian market.

Jørgen Mann, CEO of Observe Medical, commented, "Italy is a very important
market for Observe Medical due to its size and the historic strong position on
the UnoMeterT portfolio. It is great to experience positive customer feedback on
the quality of UnoMeterT SafetiT Plus from an additional market and see that the
customer acceptance means that the first trial orders are now converting into
orders with significant volumes. We have many more significant markets where
trials are ongoing and expect to be able to continue to transfer such trials to
a solid order intake going forward".

For further information, please contact:

Jørgen Mann, CEO Observe Medical
Mobile: +45 408 67558
E-mail: jorgen.mann@observemedical.com

Johan Fagerli, CFO Observe Medical
Mobile: +47 958 12765
E-mail: johan.fagerli@observemedical.com

About Observe Medical

Observe Medical is a Nordic medtech company that develops, markets and sells
innovative medtech products for the global market. The Company is committed to
improving patient welfare and patient outcomes, improving clinical data accuracy
and promoting positive health economics.

The Company seeks to drive growth by leveraging its expertise in sales and
commercialization of its broad portfolio of medical technology products, mainly
in urine measurement and ultrasound, in combination with targeted M&A and
distribution. Observe Medical is working with a network of leading distributors
to provide outstanding solutions for healthcare professionals globally.

The Company is headquartered in Oslo, Norway.

Further information is available atwww.observemedical.com.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team